Phase 2 Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are aged 18 to 65 years old at the time of their screening visit
- People who have been diagnosed with multiple sclerosis (MS) according to recognised diagnostic guidelines (the 2017 McDonald Criteria or more recent versions)
- People whose MS has been classified as a progressive form, based on recognised MS classification guidelines from 2014
- People whose level of physical disability falls within a specific range on a standard MS disability scale (EDSS score between 2.0 and 7.5)
- People who have had no clinical signs of MS relapses in the past 2 years
- People who are able to understand the trial and are willing to sign a written consent form agreeing to take part
- People who have suitable veins for blood draws or intravenous access
- People who are either using adequate contraception or are not able to become pregnant
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have been treated with alemtuzumab, a stem cell transplant using their own cells, or cladribine within the past 3 years
- People who have taken part in another clinical trial or received an experimental treatment within the past 3 months, or within 5 half-lives of the experimental treatment — whichever is the longer period
- People who are currently taking an approved MS disease-modifying therapy (a medicine used to manage MS)
- People who have taken certain MS medicines (including S1P receptor modulators, natalizumab, dimethyl fumarate, or teriflunomide) within the last 3 months, or who have received B-cell-depleting antibody treatments within the last 6 months and whose B-cell counts have not yet returned to normal (confirm with trial site)
- People who are pregnant, planning to become pregnant in the next 12 months, or who are breastfeeding
- People with a current problem with drug or alcohol misuse
- People who are unable to have MRI scans
- People who have a history of, or current signs of, a weakened immune system or cancer — with the exception of previously treated basal cell skin cancer
- People who have another significant ongoing medical condition affecting the heart, immune system, lungs, nervous system, kidneys, or other major organ that could affect safety or trial results
- People with an active or long-term infection including hepatitis B, hepatitis C, HIV, syphilis, or tuberculosis
- People who have had their spleen removed
- People with dementia, severe psychiatric illness, significant cognitive or behavioural difficulties, or other conditions that could make it difficult to follow the trial requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +32470011082
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy (Change in EDSS score); Incidence of treatment-emergent adverse events (safety and tolerability)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.